Literature DB >> 9020500

High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.

K H Yeh, A L Cheng.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020500      PMCID: PMC2063385          DOI: 10.1038/bjc.1997.79

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  18 in total

1.  Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome.

Authors:  B E Harris; J T Carpenter; R B Diasio
Journal:  Cancer       Date:  1991-08-01       Impact factor: 6.860

2.  Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity.

Authors:  M Tuchman; J S Stoeckeler; D T Kiang; R F O'Dea; M L Ramnaraine; B L Mirkin
Journal:  N Engl J Med       Date:  1985-07-25       Impact factor: 91.245

3.  Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.

Authors:  R B Diasio; T L Beavers; J T Carpenter
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

4.  The thiamine status of patients with cancer as determined by the red cell transketolase activity.

Authors:  T K Basu; J W Dickerson; R W Raven; D C Williams
Journal:  Int J Vitam Nutr Res       Date:  1974       Impact factor: 1.784

5.  Biochemical basis for fluorouracil neurotoxicity. The role of Krebs cycle inhibition by fluoroacetate.

Authors:  H Koenig; A Patel
Journal:  Arch Neurol       Date:  1970-08

6.  Severe 5-fluorouracil toxicity in a patient with decreased dihydropyrimidine dehydrogenase activity.

Authors:  A P Lyss; R C Lilenbaum; B E Harris; R B Diasio
Journal:  Cancer Invest       Date:  1993       Impact factor: 2.176

7.  Thiamin status of patients treated with drug combinations containing 5-fluorouracil.

Authors:  M Aksoy; T K Basu; J Brient; J W Dickerson
Journal:  Eur J Cancer       Date:  1980-08       Impact factor: 9.162

8.  A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma.

Authors:  B Ardalan; L Chua; E M Tian; R Reddy; K Sridhar; P Benedetto; S Richman; A Legaspi; S Waldman; L Morrell
Journal:  J Clin Oncol       Date:  1991-04       Impact factor: 44.544

9.  Dihydropyrimidine dehydrogenase activity in cancer patients.

Authors:  R A Fleming; G A Milano; M H Gaspard; P J Bargnoux; A Thyss; R Plagne; N Renée; M Schneider; F Demard
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

10.  Clearance of continuously infused 5-fluorouracil in adults having lung or gastrointestinal carcinoma with or without hepatic metastases.

Authors:  R A Floyd; C L Hornbeck; J E Byfield; J C Griffiths; S S Frankel
Journal:  Drug Intell Clin Pharm       Date:  1982-09
View more
  29 in total

1.  AMP-activated protein kinase signaling regulated expression of urea cycle enzymes in response to changes in dietary protein intake.

Authors:  Sandra K Heibel; Peter J McGuire; Nantaporn Haskins; Himani D Majumdar; Sree Rayavarapu; Kanneboyina Nagaraju; Yetrib Hathout; Kristy Brown; Mendel Tuchman; Ljubica Caldovic
Journal:  J Inherit Metab Dis       Date:  2019-08-01       Impact factor: 4.982

2.  A case of 5-fluorouracil induced encephalopathy.

Authors:  Kyung A Kwon; Hyuk-Chan Kwon; Min Chan Kim; Sung-Hyun Kim; Sung Yong Oh; Suee Lee; Hyo-Jin Kim
Journal:  Cancer Res Treat       Date:  2010-06-30       Impact factor: 4.679

3.  5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer.

Authors:  Gyanendra Acharya; Maria T Cruz Carreras; Terry Wynne Rice
Journal:  BMJ Case Rep       Date:  2017-11-21

4.  Noncirrhotic hyperammonemia causing relapsing altered mental status.

Authors:  Chibuzo Clement Odigwe; Binod Khatiwada; Christopher Holbrook; Ifeoma Sylvia Ekeh; Chukwuemeka Uzoka; Isaac Ikwu; Bishwas Upadhyay
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-10

5.  Hyperammonemic encephalopathy associated with 5-fluorouracil in a patient with previous orthotopic liver transplantation.

Authors:  Hemnishil K Marella; Rahul Peravali; Amit L Jain; Satheesh Nair; Benedict Maliakkal; Uchenna Agbim; Rajanshu Verma
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-09

Review 6.  Pharmacology of fluorinated pyrimidines: eniluracil.

Authors:  S D Baker
Journal:  Invest New Drugs       Date:  2000-11       Impact factor: 3.850

Review 7.  Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment.

Authors:  Gagandeep Singh; Jeremy H Rees; Josemir W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04       Impact factor: 10.154

8.  Hepatic encephalopathy associated with cancer or anticancer therapy.

Authors:  Kaspar J Willson; Louise M Nott; Vy T Broadbridge; Timothy Price
Journal:  Gastrointest Cancer Res       Date:  2013-01

9.  A case of Wernicke's encephalopathy following fluorouracil-based chemotherapy.

Authors:  In Jeong Cho; Hye Jung Chang; Kyoung Eun Lee; Hye Sung Won; Moon Young Choi; Eun Mi Nam; Yeung-Chul Mun; Soon Nam Lee; Chu-Myong Seong
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

10.  Valproic Acid-induced hyperammonemia in the elderly: a review of the literature.

Authors:  Vikrant Mittal; Sunanda Muralee; Rajesh R Tampi
Journal:  Case Rep Med       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.